INTERCEPT PHARMACEUTICALS, INC. Quarterly Inventory, Net in USD from Q4 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Intercept Pharmaceuticals, Inc. quarterly Inventory, Net history and growth rate from Q4 2016 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Inventory, Net for the quarter ending September 30, 2023 was $2.65M, a 57.8% decline year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.65M -$3.63M -57.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $6.27M -$619K -8.98% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $6.46M -$1.8M -21.8% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $6.46M -$1.42M -18% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $6.27M -$2.51M -28.5% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $6.89M -$2.11M -23.5% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $8.26M -$735K -8.17% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $7.88M -$1.14M -12.7% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $8.78M +$421K +5.04% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $9M +$345K +3.98% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $8.99M -$1.27M -12.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.03M +$565K +6.68% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $8.36M -$989K -10.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $8.66M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $10.3M +$2.89M +39.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $8.46M +$1.35M +19% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $9.35M +$1.87M +25.1% Sep 30, 2019 10-Q 2019-11-05
Q1 2019 $7.37M -$568K -7.16% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $7.11M +$3.63M +104% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $7.48M +$3.58M +91.8% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $5.81M +$3.13M +117% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $7.94M +$5.82M +275% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $3.48M +$1.2M +52.7% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $3.9M Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $2.68M Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $2.12M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $2.28M Dec 31, 2016 10-K 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.